TD Cowen advised on the stock performance of DCH on June 25, 2026.
1 report, 1 independent
Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen advised on the stock performance of DCH on June 25, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- TD Cowen upgraded Crescent Biopharma shares to 'strong-buy', while Wedbush reiterated 'outperform', and a CEO sold shares under a 10b5-1 plan.
- TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.
- TD Cowen raised price targets for GoodRx stock.
- TD Cowen lowered its price target for Navan, Inc. stock on September 10, 2026.